ABIZX
Price
$21.58
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
387.85M
MVCAX
Price
$32.73
Change
+$0.34 (+1.05%)
Updated
Jun 2 closing price
Net Assets
16.77B
Interact to see
Advertisement

ABIZX vs MVCAX

Header iconABIZX vs MVCAX Comparison
Open Charts ABIZX vs MVCAXBanner chart's image
ABIZX vs MVCAX Comparison Chart in %
View a ticker or compare two or three
VS
ABIZX vs. MVCAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABIZX is a Buy and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.8B vs. ABIZX (388M). MVCAX pays higher dividends than ABIZX: MVCAX (1.16) vs ABIZX (0.48). ABIZX was incepted earlier than MVCAX: ABIZX (9 years) vs MVCAX (25 years). MVCAX (0.98) is less costly to investors than ABIZX (0.79). ABIZX is a more actively managed with annual turnover of: 93.00 vs. MVCAX (24.00). MVCAX has a lower initial minimum investment than ABIZX: MVCAX (1000) vs ABIZX (5000000). MVCAX annual gain was more profitable for investors over the last year : 9.57 vs. ABIZX (-0.95). ABIZX return over 5 years is better than : 13.66 vs. MVCAX (9.01).
ABIZXMVCAXABIZX / MVCAX
Total Expense Ratio0.760.9778%
Annual Report Gross Expense Ratio0.790.9881%
Fund Existence9 years25 years-
Gain YTD-0.4617.715-6%
Front LoadN/A6%-
Min. Initial Investment50000001000500,000%
Min. Initial Investment IRAN/AN/A-
Net Assets388M16.8B2%
Annual Yield % from dividends0.481.1642%
Returns for 1 year-0.959.57-10%
Returns for 3 years19.1821.8388%
Returns for 5 years13.669.01152%
Returns for 10 yearsN/A76.09-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PANL7.900.26
+3.40%
Pangaea Logistics Solutions Ltd
HTHT44.33-0.05
-0.10%
H World Group Limited
AARD3.97-0.02
-0.50%
Aardvark Therapeutics Inc
NIVF0.93-0.02
-2.38%
NewGenIvf Group Limited
TARS57.38-1.55
-2.63%
Tarsus Pharmaceuticals